NO20054775L - Biaryl-substituerte triazoler som natriumkanalblokkere - Google Patents

Biaryl-substituerte triazoler som natriumkanalblokkere

Info

Publication number: NO20054775L
Authority: NO; Norway
Prior art keywords: compounds; pain; alone; pharmaceutically acceptable; effective amount
Prior art date: 2003-03-18

Application number

NO20054775A

Other languages

English (en)

Norwegian (no)

Other versions

NO20054775D0 (no

Inventor

Prasun K Chakravarty

Williams H Parsons

Michael H Fisher

Brenda Palucki

Min K Park

Bishan Zhou

James P Carey

Douglas E Frantz

Michael H Kress

Damian Weaver

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-18

Filing date

2005-10-17

Publication date

2005-12-16

2005-10-17 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2005-10-17 Publication of NO20054775D0 publication Critical patent/NO20054775D0/no

2005-12-16 Publication of NO20054775L publication Critical patent/NO20054775L/no

Links

239000003195 sodium channel blocking agent Substances 0.000 title 1
150000003852 triazoles Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 7
238000000034 method Methods 0.000 abstract 3
208000002193 Pain Diseases 0.000 abstract 2
239000003937 drug carrier Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
208000019901 Anxiety disease Diseases 0.000 abstract 1
208000020925 Bipolar disease Diseases 0.000 abstract 1
208000000094 Chronic Pain Diseases 0.000 abstract 1
206010065390 Inflammatory pain Diseases 0.000 abstract 1
108010052164 Sodium Channels Proteins 0.000 abstract 1
102000018674 Sodium Channels Human genes 0.000 abstract 1
208000005298 acute pain Diseases 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
206010015037 epilepsy Diseases 0.000 abstract 1
208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
201000006417 multiple sclerosis Diseases 0.000 abstract 1
208000004296 neuralgia Diseases 0.000 abstract 1
208000021722 neuropathic pain Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002691 topical anesthesia Methods 0.000 abstract 1
-1 triazole compounds Chemical class 0.000 abstract 1
208000009935 visceral pain Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20054775A 2003-03-18 2005-10-17 Biaryl-substituerte triazoler som natriumkanalblokkere NO20054775L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45595203P	2003-03-18	2003-03-18
PCT/US2004/007830 WO2004083190A1 (en)	2003-03-18	2004-03-12	Biaryl substituted triazoles as sodium channel blockers

Publications (2)

Publication Number	Publication Date
NO20054775D0 NO20054775D0 (no)	2005-10-17
NO20054775L true NO20054775L (no)	2005-12-16

Family

ID=33030073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20054775A NO20054775L (no)	2003-03-18	2005-10-17	Biaryl-substituerte triazoler som natriumkanalblokkere

Country Status (34)

Country	Link
US (2)	US7326726B2 (pl)
EP (1)	EP1606269B1 (pl)
JP (1)	JP4482554B2 (pl)
KR (1)	KR100737721B1 (pl)
CN (2)	CN101289428A (pl)
AR (1)	AR044503A1 (pl)
AT (1)	ATE412639T1 (pl)
AU (1)	AU2004221885C1 (pl)
BR (1)	BRPI0408407A (pl)
CA (1)	CA2519252C (pl)
CL (1)	CL2004000551A1 (pl)
CY (1)	CY1108720T1 (pl)
DE (1)	DE602004017438D1 (pl)
DK (1)	DK1606269T3 (pl)
EC (1)	ECSP056018A (pl)
EG (1)	EG25994A (pl)
ES (1)	ES2314387T3 (pl)
HR (1)	HRP20050816A2 (pl)
IS (1)	IS8001A (pl)
JO (1)	JO2480B1 (pl)
MA (1)	MA27665A1 (pl)
MX (1)	MXPA05009847A (pl)
MY (1)	MY142651A (pl)
NO (1)	NO20054775L (pl)
NZ (1)	NZ542205A (pl)
PE (1)	PE20041066A1 (pl)
PL (1)	PL1606269T3 (pl)
PT (1)	PT1606269E (pl)
RU (1)	RU2356897C2 (pl)
SI (1)	SI1606269T1 (pl)
TW (1)	TWI337605B (pl)
UA (1)	UA81660C2 (pl)
WO (2)	WO2004083190A1 (pl)
ZA (1)	ZA200506906B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1587821T6 (da)	2002-12-19	2025-05-26	Scripps Research Inst	Sammensætninger og fremgangsmåder til stabilisering af trans-thyretin og inhibering af transthyretin-fejlfoldning
MY142651A (en) *	2003-03-18	2010-12-15	Merck Sharp & Dohme	Biaryl substituted triazoles as sodium channel blockers
AU2004289694B2 (en) *	2003-11-10	2010-05-13	Merck Sharp & Dohme Corp.	Substituted triazoles as sodium channel blockers
WO2005112913A1 (en)	2004-05-20	2005-12-01	The Scripps Research Institute	Transthyretin stabilization
EP1943216B1 (en)	2005-10-10	2010-06-30	Glaxo Group Limited	Prolinamide derivatives as sodium channel modulators
TW200730494A (en)	2005-10-10	2007-08-16	Glaxo Group Ltd	Novel compounds
TW200728258A (en)	2005-10-10	2007-08-01	Glaxo Group Ltd	Novel compounds
US8093268B2 (en)	2007-01-24	2012-01-10	Glaxo Group Limited	Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
NZ579403A (en) *	2007-02-08	2012-03-30	Synta Pharmaceuticals Corp	Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
ES2569660T3 (es)	2007-06-08	2016-05-12	Mannkind Corporation	Inhibidores de la IRE-1alfa
HUE034911T2 (hu)	2009-07-27	2018-03-28	Gilead Sciences Inc	Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
EP2588197B1 (en)	2010-07-02	2014-11-05	Gilead Sciences, Inc.	Fused heterocyclic compounds as ion channel modulators
WO2012154760A1 (en)	2011-05-10	2012-11-15	Gilead Sciences, Inc.	Fused heterocyclic compounds as sodium channel modulators
UY34171A (es)	2011-07-01	2013-01-31	Gilead Sciences Inc	Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (pl)	2011-07-01	2018-04-28
WO2013038351A1 (en)	2011-09-16	2013-03-21	Pfizer Inc.	Solid forms of a transthyretin dissociation inhibitor
WO2013131018A1 (en) *	2012-03-02	2013-09-06	Zalicus Pharmaceuticals Ltd.	Biaryl inhibitors of the sodium channel
TWI568722B (zh)	2012-06-15	2017-02-01	葛蘭馬克製藥公司	作爲ｍＰＧＥＳ－１抑制劑之三唑酮化合物
WO2014152738A1 (en)	2013-03-15	2014-09-25	Bristol-Myers Squibb Company	Lxr modulators
WO2016102967A1 (en)	2014-12-23	2016-06-30	Convergence Pharmaceuticals Limited	Process for preparing alpha-carboxamide pyrrolidine derivatives
JP6616244B2 (ja) *	2015-05-29	2019-12-04	北興化学工業株式会社	新規なヒドロキシフェニルボロン酸エステルとその製造方法、およびヒドロキシビフェニル化合物の製造法
EP3691634A4 (en)	2017-10-05	2021-03-31	Biogen Inc.	PROCESS FOR THE PREPARATION OF PYRROLIDINE ALPHA-CARBOXAMIDE DERIVATIVES
KR102512548B1 (ko)	2017-12-22	2023-03-22	삼성디스플레이 주식회사	유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
BR112020018403A2 (pt) *	2018-03-09	2020-12-22	Pi Industries Ltd.	Compostos heterocíclicoscomo fungicidas
CN108863965A (zh) *	2018-06-25	2018-11-23	青岛科技大学	一锅法制备1,2,4-三氮唑-3-甲酰胺的方法
CN108794413A (zh) *	2018-06-25	2018-11-13	青岛科技大学	一种1,2,4-三氮唑-3-甲酰胺的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US875782A (en) *	1907-04-29	1908-01-07	Walter H Cook	Fast-nut.
TW226993B (pl) *	1992-05-29	1994-07-21	Kumiai Chemical Industry Co
US5455252A (en)	1993-03-31	1995-10-03	Syntex (U.S.A.) Inc.	Optionally substituted 6,8-quinolines
JP3682075B2 (ja) *	1993-04-16	2005-08-10	クミアイ化学工業株式会社	トリアゾール誘導体及び殺虫、殺ダニ剤
MY129541A (en) *	1996-06-25	2007-04-30	Novartis Ag	Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
IT1292091B1 (it) *	1997-06-05	1999-01-25	Geange Ltd	Derivati eterociclici aromatici azotati,procedimento per la loro preparazione e loro impiego come antigestativi,immunosoppressori e
GB9726987D0 (en)	1997-12-22	1998-02-18	Glaxo Group Ltd	Compounds
IL145508A0 (en)	1999-03-26	2002-06-30	Euro Celtique Sa	Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
AR029489A1 (es)	2000-03-10	2003-07-02	Euro Celtique Sa	Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
JP2004532234A (ja) *	2001-04-27	2004-10-21	バーテックス　ファーマシューティカルズ　インコーポレイテッド	トリアゾール由来キナーゼインヒビターおよびその使用
US6797722B2 (en) *	2002-05-03	2004-09-28	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
US6875782B2 (en) *	2002-07-09	2005-04-05	Bristol-Myers Squibb Company	Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
KR100467668B1 (ko) *	2002-08-07	2005-01-24	씨제이 주식회사	1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
KR100470075B1 (ko) *	2002-11-21	2005-02-05	씨제이 주식회사	1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
JO2397B1 (en) *	2002-12-20	2007-06-17	ميرك شارب اند دوم كوربوريشن	Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
MY142651A (en) *	2003-03-18	2010-12-15	Merck Sharp & Dohme	Biaryl substituted triazoles as sodium channel blockers
AU2004289694B2 (en) *	2003-11-10	2010-05-13	Merck Sharp & Dohme Corp.	Substituted triazoles as sodium channel blockers

2004
- 2004-03-11 MY MYPI20040842A patent/MY142651A/en unknown
- 2004-03-11 AR ARP040100789A patent/AR044503A1/es unknown
- 2004-03-12 AT AT04720360T patent/ATE412639T1/de active
- 2004-03-12 WO PCT/US2004/007830 patent/WO2004083190A1/en not_active Ceased
- 2004-03-12 JP JP2006507122A patent/JP4482554B2/ja not_active Expired - Fee Related
- 2004-03-12 NZ NZ542205A patent/NZ542205A/en not_active IP Right Cessation
- 2004-03-12 UA UAA200509759A patent/UA81660C2/ru unknown
- 2004-03-12 MX MXPA05009847A patent/MXPA05009847A/es active IP Right Grant
- 2004-03-12 PT PT04720360T patent/PT1606269E/pt unknown
- 2004-03-12 US US10/799,230 patent/US7326726B2/en not_active Expired - Lifetime
- 2004-03-12 SI SI200430959T patent/SI1606269T1/sl unknown
- 2004-03-12 EP EP04720360A patent/EP1606269B1/en not_active Expired - Lifetime
- 2004-03-12 BR BRPI0408407-1A patent/BRPI0408407A/pt not_active IP Right Cessation
- 2004-03-12 DK DK04720360T patent/DK1606269T3/da active
- 2004-03-12 CA CA002519252A patent/CA2519252C/en not_active Expired - Fee Related
- 2004-03-12 RU RU2005132168/04A patent/RU2356897C2/ru not_active IP Right Cessation
- 2004-03-12 WO PCT/US2004/007597 patent/WO2004083189A1/en not_active Ceased
- 2004-03-12 ES ES04720360T patent/ES2314387T3/es not_active Expired - Lifetime
- 2004-03-12 CN CNA2008101000997A patent/CN101289428A/zh active Pending
- 2004-03-12 KR KR1020057017327A patent/KR100737721B1/ko not_active Expired - Fee Related
- 2004-03-12 CN CNA200480013089XA patent/CN1788002A/zh active Pending
- 2004-03-12 PL PL04720360T patent/PL1606269T3/pl unknown
- 2004-03-12 DE DE602004017438T patent/DE602004017438D1/de not_active Expired - Lifetime
- 2004-03-12 HR HR20050816A patent/HRP20050816A2/hr not_active Application Discontinuation
- 2004-03-12 AU AU2004221885A patent/AU2004221885C1/en not_active Ceased
- 2004-03-14 JO JO200430A patent/JO2480B1/en active
- 2004-03-16 PE PE2004000280A patent/PE20041066A1/es not_active Application Discontinuation
- 2004-03-17 CL CL200400551A patent/CL2004000551A1/es unknown
- 2004-03-17 TW TW093107083A patent/TWI337605B/zh not_active IP Right Cessation
2005
- 2005-08-29 IS IS8001A patent/IS8001A/is unknown
- 2005-08-29 ZA ZA200506906A patent/ZA200506906B/xx unknown
- 2005-09-06 MA MA28481A patent/MA27665A1/fr unknown
- 2005-09-14 EC EC2005006018A patent/ECSP056018A/es unknown
- 2005-09-18 EG EGNA2005000548 patent/EG25994A/xx active
- 2005-10-17 NO NO20054775A patent/NO20054775L/no not_active Application Discontinuation
2008
- 2008-01-30 US US12/011,967 patent/US7572822B2/en not_active Expired - Lifetime
2009
- 2009-01-15 CY CY20091100054T patent/CY1108720T1/el unknown

Also Published As

Publication number	Publication date
JP2006520782A (ja)	2006-09-14
AU2004221885B2 (en)	2010-04-22
DE602004017438D1 (de)	2008-12-11
CL2004000551A1 (es)	2005-01-21
TWI337605B (en)	2011-02-21
US20050119261A1 (en)	2005-06-02
PE20041066A1 (es)	2005-01-22
NO20054775D0 (no)	2005-10-17
US7326726B2 (en)	2008-02-05
RU2005132168A (ru)	2006-04-27
NZ542205A (en)	2008-11-28
JP4482554B2 (ja)	2010-06-16
MY142651A (en)	2010-12-15
EP1606269B1 (en)	2008-10-29
DK1606269T3 (da)	2009-02-09
IS8001A (is)	2005-08-29
ZA200506906B (en)	2007-02-28
HRP20050816A2 (hr)	2006-04-30
CN101289428A (zh)	2008-10-22
PT1606269E (pt)	2008-12-16
CA2519252A1 (en)	2004-09-30
ES2314387T3 (es)	2009-03-16
KR100737721B1 (ko)	2007-07-11
RU2356897C2 (ru)	2009-05-27
US7572822B2 (en)	2009-08-11
AU2004221885A1 (en)	2004-09-30
TW200505876A (en)	2005-02-16
SI1606269T1 (sl)	2009-02-28
ECSP056018A (es)	2006-01-27
EG25994A (en)	2012-11-28
EP1606269A1 (en)	2005-12-21
BRPI0408407A (pt)	2006-03-21
CA2519252C (en)	2008-11-18
AR044503A1 (es)	2005-09-14
WO2004083190A1 (en)	2004-09-30
PL1606269T3 (pl)	2009-04-30
JO2480B1 (en)	2009-01-20
CN1788002A (zh)	2006-06-14
CY1108720T1 (el)	2013-09-04
KR20050109583A (ko)	2005-11-21
ATE412639T1 (de)	2008-11-15
MA27665A1 (fr)	2005-12-01
US20080171777A1 (en)	2008-07-17
UA81660C2 (ru)	2008-01-25
AU2004221885C1 (en)	2010-09-23
WO2004083189A1 (en)	2004-09-30
MXPA05009847A (es)	2005-12-05

Legal Events

Date	Code	Title	Description
2013-11-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
UA81660C2 (ru)	2008-01-25	Биарилзамещённые триазолы как блокираторы натриевых каналов
NO20091620L (no)	2009-07-09	Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser
WO2007112345A3 (en)	2007-11-29	Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
WO2007145922A3 (en)	2008-08-21	Benzazepinones as sodium channel blockers
WO2005047270A3 (en)	2005-09-22	Substituted triazoles as sodium channel blockers
WO2011027249A3 (en)	2011-09-01	Benzimidazole derivatives
WO2001081310A8 (en)	2002-02-07	1-aroyl-piperidinyl benzamidines
WO2007112357A3 (en)	2007-12-27	Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
WO2009066041A3 (fr)	2009-12-17	Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2010095768A8 (en)	2011-08-04	4 -isopropylphenyl glucitol compounds as sglt1 inhibitors
IL181095A0 (en)	2007-07-04	Polysulfated glycosides and salts thereof
WO2007075524A3 (en)	2008-11-20	Substituted piperidines as calcium channel blockers
MX2022009967A (es)	2022-10-21	Compuestos para el tratamiento de la infeccion por coronavirus.
NO20002099L (no)	2000-06-29	6,11-bro-erytromycinderivater
BR0311136A (pt)	2007-04-27	composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero
TNSN05246A1 (en)	2007-06-11	Use of 10-hydroxy-10, 11-dihydrocarbamazepine derivatives for the treatment of affective disorders
WO2001014358A3 (en)	2001-05-17	Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
WO2010045582A3 (en)	2010-07-29	Compositions and methods for treating or preventing hypoxic or ischemic injury
WO2005037213A3 (en)	2006-07-13	Antiinflammatory inhibitors of respiratory burst in adherent neutrophils
MX2023004435A (es)	2023-05-08	Compuestos y composiciones para el tratamiento de la criptosporidiosis.
JP2008531613A5 (pl)	2009-04-02
WO2007084394A3 (en)	2008-01-24	2,5 diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers
WO2023217800A3 (en)	2023-12-21	Synthesis of glycosylated hydroxytryptamine compounds and methods of their use
WO2024239001A3 (en)	2025-03-06	Isoandrographolide analogs and method for treatment using the same
GEP20135858B (en)	2013-06-25	Compound with serotoninergic activity, method of its preparation, and pharmaceutical composition containing thereof